Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa ; day:24 ; month:2 ; year:2017 ; pages:1-16
Clinical pharmacokinetics ; (24.2.2017), 1-16
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Creator
-
Mittur, Aravind
- Contributor
-
Gupta, Suneel
Modi, Nishit B.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-017-0511-y
- URN
-
urn:nbn:de:1111-201703179018
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mittur, Aravind
- Gupta, Suneel
- Modi, Nishit B.
- SpringerLink (Online service)
Other Objects (12)
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
Capsule-C: an improved Steinernema carpocapsae capsule formulation for controlling Agrotis ipsilon Hufnagel (Lepidoptera: Noctuidae)
Formulation, pharmacokinetics, and antibacterial activity of florfenicol-loaded niosome
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
Predicting levodopa-induced dyskinesia
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
Capsule-C: an improved Steinernema carpocapsae capsule formulation for controlling Agrotis ipsilon Hufnagel (Lepidoptera: Noctuidae)
Formulation, pharmacokinetics, and antibacterial activity of florfenicol-loaded niosome
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
Predicting levodopa-induced dyskinesia
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
Capsule-C: an improved Steinernema carpocapsae capsule formulation for controlling Agrotis ipsilon Hufnagel (Lepidoptera: Noctuidae)
Formulation, pharmacokinetics, and antibacterial activity of florfenicol-loaded niosome
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment